bullish
Kyowa Hakko Kirin 3Q FY18 (YE Dec'18) Results - First Glance
277 Views30 Oct 2018 23:21
Key highlights
Continued genericization / ongoing price cuts led decline in domestic pharma sales by ~10% to ~¥43b
However, overseas sales grew 16%...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Kyowa Hakko Kirin 3Q FY18 (YE Dec'18) Results - First Glance30 Oct 2018
- One-Time Income Resulted in Strong 1H FY18 Performance – Crysvita Is Key Driver.24 Aug 2018
x